An electronic copy of a report obtained by the Taipei Times on the yet-to-be-approved sale of Nan Shan Life Insurance Co claims that the backers of the Hong Kong-based consortium led by Primus Financial Holding Ltd and China Strategic Holding may include individuals found guilty of financial irregularities as well as close relatives of senior members of the Chinese Communist Party.
The English translation of the report, which is dated March 10 and comes from the office of Democratic Progressive Party Legislator Pan Meng-an (潘孟安), also mentions risks of stock speculation and raises questions about the qualifications of major shareholders and the use of “shell” companies.
Pan's office told the Taipei Times yesterday the report drew from newspapers, magazines and investors in Hong Kong. The office confirmed the report received “government help,” but would not specify which agency or agencies were involved.
The document claims that Primus Pacific Partner (Hong Kong) Co Ltd (Primus Pacific) — which provided funding for Primus Financial — receives “some funding” from the state-owned Beijing Enterprises Holding Ltd, while China Strategic, which according to the report is in very poor financial situation, “is … truly [a] 'shell' company.”
Other partners in the conglomerate appear to have been “tailor- made” for the Nan Shan bid, the report says.
Previous shareholders, board members and top managers at China Strategic “are backed by mainland Chinese money,” the report says, adding that: “Information publicly disclosed by [the] Hong Kong Securities and Futures Commission [demonstrates] that the firm has been financially controlled by Chinese capital.”
Topping the list is a well-known Shandong-born Chinese speculator who is reportedly at large over his involvement in two cases of stock speculation and insider trading.
Primus Financial was used to raise capital and hired Huan Guocang (宦國倉) as a representative, the report claims. The Shanghai-born Huan is the CEO of Primus Pacific and chairman of Primus Financial, as well as the director of Beijing Development (Hong Kong) Ltd, which is invested by Beijing Enterprises.
Following revelations of Chinese investment in the Nan Shan bid, Huan cut all ties to the case, the report says.
Primus Pacific president and general manager Li Wenlei (李聞雷) is the son of former Chinese vice premier Li Lanqing (李嵐清), the report says.
The Primus group, the report says, “is backed by ... mainland China's princeling party,” alleging that the son of former vice president Zeng Qinghong (曾慶紅), Zeng Wei (曾偉), and his brother, Zeng Qinghuai (曾慶淮), were both members of the group.
Among the principal parties at China Strategic are Shanghai-born Gao Yang (高央), who was the executive director and chief executive officer of the firm in 2006. While he resigned in 2007, he still owns a 23 percent stake — the largest share — in the company, the report says.
Current shareholders at China Strategic include two Hong Kong stock speculators, who were allegedly handed down administrative penalties by the Hong Kong Securities and Futures Commission (FSC) for “rampant speculation,” while another was allegedly indicted by the commission, also for rampant speculation, to which he confessed in 2004.
At press time, requests by the Taipei Times to the Hong Kong FSC for confirmation remained unanswered. As per Taiwanese law, if it were found that bidders have a criminal past, the Nan Shan bid would likely be turned down.
“Funding sources of China Strategic basically comes [sic] from China and Hong Kong, while the shareholders are made up of China and Hong Kong tycoons as well as speculators,” the report said, adding that this proves that China Strategic “is indeed controlled by mainlanders.”
“China Strategic, Primus Financial or its investor, Primus Pacific, all lack ... experience in managing financial holdings, let alone in [the] life insurance industry. In addition, the newly established Primus Nan Shan Holding Company was registered ... less than a year [earlier] for this case. Therefore, observers have called it a 'shell' corporation for falling short on both capital structure and a decent managerial team,” the report says.
The report concludes: “Most people involved in this case are Chin[ese] officials, mainlanders, or [individuals] with a Chinese background. Although it [is] hard to keep track of the final beneficiary due to ... several transfer[s] [in] the investment, concerns about ... mainland Chinese money still exist.”
American International Group sold Nan Shan to Primus Financial on Oct. 12 for US$2.15 billion, which filed an application with the Ministry of Economic Affairs' Investment Commission in November. On Feb. 12, Primus and China Strategic sent a revised application after the commission requested that it provide more information on its investors and sources of funding.
On March 11, Minister of Economic Affairs Shih Yen-shiang (施顏祥) said there was no evidence that Chinese capital was involved in Primus Financial, adding that none of the 44 investors who provided information in the application were Chinese citizens.
Several of the stakeholders at China Strategic, which has an 80 percent stake in Primus Nan Shan, are Hong Kong-UK dual nationals, but none are Chinese citizens, he said.
Fan Liang-tung (范良棟), head of the Investment Commission, said on Monday he could not comment.
“The case is still in the evaluation and approval stage. I am not in a position to comment,” Fan told the Taipei Times by telephone.
The outcome of the commission's investigation is expected to be announced this week.
ADDITIONAL REPORTING BY JASON TAN
NEXT STEP? The contract chipmaker said it would decide whether to add more plants based on operation efficiency, cost economics and demand Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is planning to build several more chipmaking fabs in the US state of Arizona beyond the one already planned, three people familiar with the matter said. TSMC, the world’s largest contract chipmaker, announced in May last year that it would build a US$12 billion fab in Arizona. The 12-inch wafer fab in Phoenix is expected to start mass production in 2024, the Investment Commission said in December, when it approved the plan. Three sources familiar with the matter, speaking on condition of anonymity as they were not authorized to speak to the media, said that up
VIRUS CURBS: Visiting people staying at healthcare and long-term care facilities in Taipei, New Taipei City and Taoyuan is banned until May 17, the CECC announced The Central Epidemic Command Center (CECC) yesterday banned visits to patients or residents at healthcare and long-term care facilities in three cities until May 17. It also reported six imported cases of COVID-19 and two cases with unclear infection sources. As the number of locally transmitted cases rises, some of whom have visited many places in Taipei, New Taipei City and Taoyuan, enhanced disease prevention measures have to be implemented in the three cities, said Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center. “Visiting people staying at healthcare and long-term care facilities in Taipei, New Taipei City and
TAKING NOTICE: In the first time that G7 foreign ministers have mentioned Taiwan in a joint communique, they called for ‘peace and stability across the Taiwan Strait’ The Presidential Office yesterday thanked the G7 foreign ministers for their strong support of Taiwan after the group in its joint statement on Wednesday called for the nation’s participation in the WHO, and the importance of peace and stability across the Taiwan Strait. The ministers in a communique issued at the end of their three-day meeting declared support for “Taiwan’s meaningful participation” in WHO forums and the World Health Assembly (WHA). “The international community should be able to benefit from the experience of all partners, including Taiwan’s successful contribution to the tackling of the COVID-19 pandemic,” it said. The statement included a section
UP TO TWO DAYS: Minister of Health and Welfare Chen Shih-chung said that most who got the shot and felt discomfort only felt ill for the first two days Employees can ask for unpaid COVID-19 vaccination leave, from the day of their shot until the end of the next day, the Central Epidemic Command Center (CECC) announced yesterday, adding that the policy takes effect immediately. “The policy of unpaid COVID-19 vaccination leave will be implemented starting on May 5, and all workers and civil servants will be eligible,” Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, told a news conference. Leave can be taken on the day of vaccination and if recipients feel discomfort after getting the shot, they can extend the leave to all of the